InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（59 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
59
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Mathew Aby J., Executive Vice President and Chief Scientific Officer. Insider active across 1 company, notably Biolife Solutions INC. Cumulatively, 107 filings have been recorded. Breakdown: 0 buy · 59 sells. Total volume traded: €1.4m. Activity tracked since 17 May 2021. The latest transaction was filed on 7 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mathew Aby J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报107 总计
516 股@ US$27.790.0010% mcap0.7% 占其流量Common StockSEC:0001628280-26-048053:0
564 股Common StockSEC:0001628280-26-044694:0
627 股Common StockSEC:0001628280-26-042284:0
515 股@ US$19.270.4% 占其流量Common StockSEC:0001628280-26-024767:0
2,255 股@ US$19.122.1% 占其流量Common StockSEC:0001628280-26-020574:0
529 股@ US$20.740.5% 占其流量Common StockSEC:0001628280-26-015340:0
20,096 股Common StockSEC:0001628280-26-012473:0
405 股@ US$25.590.5% 占其流量Common StockSEC:0001628280-26-001383:0
631 股@ US$25.130.8% 占其流量Common StockSEC:0001628280-25-057724:0
526 股@ US$26.740.7% 占其流量Common StockSEC:0001628280-25-054278:0
509 股@ US$27.360.6% 占其流量Common StockSEC:0001628280-25-045017:0
630 股@ US$26.830.8% 占其流量Common StockSEC:0001556355-25-000003:0
531 股@ US$25.440.7% 占其流量Common StockSEC:0001628280-25-041304:0
536 股@ US$22.270.6% 占其流量Common StockSEC:0001628280-25-034682:0
637 股@ US$23.700.8% 占其流量Common StockSEC:0001628280-25-031102:0
521 股@ US$22.460.5% 占其流量Common StockSEC:0001628280-25-028700:0
569 股@ US$20.110.5% 占其流量Common StockSEC:0001628280-25-017588:0
10,589 股@ US$22.6611.1% 占其流量Common StockSEC:0001628280-25-016633:0
22,919 股Common StockSEC:0001628280-25-014184:0
1,597 股@ US$25.001.8% 占其流量Common StockSEC:0001628280-25-012679:0
425 股@ US$25.460.5% 占其流量Common StockSEC:0001628280-25-010565:0
92 股@ US$26.540.1% 占其流量Common StockSEC:0001628280-25-005844:0
404 股@ US$27.020.5% 占其流量Common StockSEC:0001628280-25-000986:0
7,604 股@ US$27.339.9% 占其流量Common StockSEC:0001628280-24-052104:0
523 股@ US$27.200.7% 占其流量Common StockSEC:0001628280-24-049479:0
107 条申报中的 25 条
About Mathew Aby J.
Mathew Aby J. is Executive Vice President and Chief Scientific Officer at Biolife Solutions INC (XNAS). He has 106 filings in total, and across the sampled filings from 2021-05-19 to 2026-06-22, the transactions are sales for EUR 1,429,847 and no purchases.
